Armistice Capital, LLC is Director of AYTU BIOPHARMA, INC. Currently has a direct ownership of 1.34 Million shares of AYTU, which is worth approximately $1.85 Million. The most recent transaction as insider was on Mar 29, 2021, when has been sold 2,085 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.34M
0% 3M change
0% 12M change
Total Value Held $1.85 Million

ARMISTICE CAPITAL, LLC Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 29 2021
BUY
Other acquisition or disposition
-
2,085 Added 0.16%
1,342,378 Common Stock
Mar 20 2021
BUY
Other acquisition or disposition
-
6,959 Added 0.52%
1,340,293 Common Stock
Dec 11 2020
BUY
Open market or private purchase
$8,000,004 $6.0 p/Share
1,333,334 Added 50.0%
1,333,334 Common Stock
Apr 27 2020
SELL
Open market or private sale
$9,298,236 $1.82 p/Share
5,108,921 Reduced 100.0%
0 Common Stock
Apr 27 2020
BUY
Exercise of conversion of derivative security
$6,250,000 $1.25 p/Share
5,000,000 Added 49.46%
5,108,921 Common Stock
Apr 06 2020
BUY
Other acquisition or disposition
-
108,920 Added 50.0%
108,921 Common Stock
Mar 10 2020
SELL
Payment of exercise price or tax liability
$1,933,931 $1.3 p/Share
1,487,639 Reduced 7.59%
18,119,637 Common Stock
Mar 10 2020
SELL
Open market or private sale
$27,092,966 $1.23 p/Share
22,026,801 Reduced 100.0%
1 Common Stock
Mar 10 2020
BUY
Exercise of conversion of derivative security
$17,818,118 $1.17 p/Share
15,229,161 Added 40.88%
22,026,802 Common Stock
Feb 14 2020
BUY
Other acquisition or disposition
-
335,279 Added 3.89%
8,285,279 Common Stock
Dec 20 2019
BUY
Open market or private purchase
$22,880 $0.88 p/Share
26,000 Added 0.33%
7,950,000 Common Stock
Dec 19 2019
BUY
Open market or private purchase
$44,870 $0.85 p/Share
52,788 Added 0.66%
7,924,000 Common Stock
Oct 30 2019
BUY
Conversion of derivative security
$2,421,010 $0.88 p/Share
2,751,148 Added 25.9%
7,871,212 Common Stock
Apr 18 2019
BUY
Other acquisition or disposition
-
3,120,064 Added 37.86%
5,120,064 Common Stock

Also insider at

AVTX
Avalo Therapeutics, Inc. Healthcare
BBI
Brickell Biotech, Inc. Healthcare
ALIM
ALIMERA SCIENCES INC Healthcare
KPRX
KIORA PHARMACEUTICALS INC Healthcare
SAVA
CASSAVA SCIENCES INC Healthcare
DFRG
Del Frisco's Restaurant Group, Inc.
VLRX
Valeritas Holdings Inc.
BPTH
BIO-PATH HOLDINGS INC Healthcare
ACHV
ACHIEVE LIFE SCIENCES, INC. Healthcare
AMAG
AMAG PHARMACEUTICALS, INC.
RSLS
ReShape Weightloss Inc.
INNV
INNOVUS PHARMACEUTICALS, INC.
ONTX
Onconova Therapeutics, Inc. Healthcare
VXRT
Vaxart, Inc. Healthcare
TTPH
TETRAPHASE PHARMACEUTICALS INC
TENX
TENAX THERAPEUTICS, INC. Healthcare
CYTH
Cyclo Therapeutics, Inc. Healthcare
RSLS
ReShape Lifesciences Inc. Healthcare
ACL

Armistice Capital, LLC

Director
New York, NY

Track Institutional and Insider Activities on AYTU

Follow AYTU BIOPHARMA, INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AYTU shares.

Notify only if

Insider Trading

Get notified when an Aytu Biopharma, Inc insider buys or sells AYTU shares.

Notify only if

News

Receive news related to AYTU BIOPHARMA, INC

Track Activities on AYTU